Announcements Trials

Browse Landscape

Phase

Status

Completed 39 Terminated 15 Unknown 10 Recruiting 10 Not yet recruiting 3 Active not recruiting 2 Withdrawn 1 No longer available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Pancreatic Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Oxaliplatin 20 Fluorouracil 20 Leucovorin 19 Bevacizumab 16 Cetuximab 13 Irinotecan 12 Capecitabine 8 regorafenib 5 Radiotherapy 5 Nivolumab 5 Drug Therapy 5 aflibercept 4 Radiosurgery 4 Neoadjuvant Therapy 4 Magnetic Resonance Spectroscopy 4 Chemotherapy, Adjuvant 4 Biopsy 4 pembrolizumab 3 durvalumab 3 atezolizumab 3 Specimen Handling 3 Folfox protocol 3 Cyclophosphamide 3 trifluridine tipiracil drug combination 2 tremelimumab 2 tislelizumab 2 poly(I).poly(c12,U) 2 futuximab 2 fludarabine 2 avelumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Colorectal Neoplasms × IFL protocol × Clear all

NCT07323576 2026-02-09

INAVO-CRC

Hoffmann-La Roche

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡